217 Publications (Page 7 of 9)
2008
Cetuximab in non-small cell lung cancer.
Ademuyiwa, Foluso O and Hanna, Nasser H
Expert opinion on biological therapy, vol. 8, (no. 1), pp. 107-13, 2008/Jan. | Journal Article
 
Gefitinib Plus Celecoxib in Chemotherapy-Naïve Patients with Stage IIIB/IV Non-small Cell Lung Cancer: A Phase II Study from the Hoosier Oncology Group
Agarwala, Anuj⋅Agarwala, Anuj⋅Fisher, William⋅Fisher, William⋅Bruetman, Daniel⋅Bruetman, Daniel⋅McClean, John⋅McClean, John⋅Taber, David⋅Taber, David⋅Titzer, Michael⋅Titzer, Michael⋅Juliar, Beth⋅Juliar, Beth⋅Yu, Menggang⋅Yu, Menggang⋅Breen, Tim⋅Breen, Tim⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Hanna, Nasser and Hanna, Nasser
Journal of Thoracic Oncology, vol. 3, (no. 4), pp. 379, April 2008. | Journal Article
 
Is"chemobrain" a transient state? A prospective pilot study among persons with non-small cell lung cancer
Whitney, K.A.⋅Whitney, Kriscinda A⋅Whitney, Kriscinda A⋅Lysaker, P.H.⋅Lysaker, Paul H⋅Lysaker, Paul H⋅Steiner, A.R.⋅Steiner, Amy R⋅Steiner, Amy R⋅Hook, J.N.⋅Hook, Julie N⋅Hook, Julie N⋅Estes, Deborah D⋅Estes, Deborah D⋅Estes, D.D.⋅Hanna, N.H.⋅Hanna, Nasser H and Hanna, Nasser H
The journal of supportive oncology, vol. 6, (no. 7), pp. 313, 2008 Sep-Oct. | Journal Article
 
Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology.
Hanna, Nasser H⋅Hanna, Nasser⋅Neubauer, Marcus⋅Neubauer, Marcus⋅Yiannoutsos, Constantin T⋅Yiannoutsos, Constantin⋅Mc Garry, Ronald C⋅McGarry, Ronald⋅Arseneau, James⋅Arseneau, James⋅Ansari, Rafat⋅Ansari, Rafat⋅Reynolds, Craig⋅Reynolds, Craig⋅Govindan, Ramaswamy⋅Govindan, Ramaswamy⋅Melnyk, Anton⋅Melnyk, Anton⋅Fisher, William⋅Fisher, William⋅Richards, Donald⋅Richards, Donald⋅Bruetman, Daniel⋅Bruetman, Daniel⋅Anderson, Thomas⋅Anderson, Thomas⋅Chowhan, Naveed⋅Chowhan, Naveed⋅Nattam, Sreenivasa⋅Nattam, Sreenivasa⋅Mantravadi, Prasad⋅Mantravadi, Prasad⋅Johnson, Cynthia⋅Johnson, Cynthia⋅Breen, Tim⋅Breen, Tim⋅White, Angela⋅White, Angela⋅Einhorn, Lawrence and Einhorn, Lawrence
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 26, (no. 35), pp. 5755-60, 2008/Dec/10. | Journal Article
 
Second-line treatment of advanced non-small cell lung cancer.
Gridelli, Cesare⋅Ardizzoni, Andrea⋅Ciardiello, Fortunato⋅Hanna, Nasser H⋅Heymach, John V⋅Perrone, Francesco⋅Rosell, Rafael⋅Shepherd, Frances A⋅Thatcher, Nick⋅Vansteenkiste, Johan⋅De Petris, Luigi⋅Di Maio, Massimo and De Marinis, Filippo
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol. 3, (no. 4), pp. 430-40, 2008/Apr. | Journal Article
 
Summary statement novel agents in the treatment of lung cancer: Fifth Cambridge Conference assessing opportunities for combination therapy.
Lynch, Thomas J⋅Blumenschein, George R⋅Engelman, Jeffrey A⋅Espinoza-Delgado, Igor⋅Govindan, Ramaswamy⋅Hanke, Jeff⋅Hanna, Nasser H⋅Heymach, John V⋅Hirsch, Fred R⋅Janne, Pasi A⋅Lilenbaum, Rogerio C⋅Natale, Ronald B⋅Riely, Gregory J⋅Sequist, Lecia V⋅Shapiro, Geoffrey⋅Shaw, Alice T⋅Shepherd, Frances A⋅Socinski, Mark⋅Sorensen, A. Gregory⋅Wakelee, Heather A and Weitzman, Aaron
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol. 3, (no. 6 Suppl 2), pp. S107-12, 2008/Jun. | Journal Article
 
Unlocking the Biological Clues of Lung Cancer
Hanna, Nasser
Journal of Thoracic Oncology, vol. 3, (no. 8), pp. 810, August 2008. | Journal Article
2007
A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study.
Navari, Rudolph M⋅Einhorn, Lawrence H⋅Loehrer, Patrick J⋅Passik, Steven D⋅Vinson, Jake⋅McClean, John⋅Chowhan, Naveed⋅Hanna, Nasser H and Johnson, Cynthia S
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, vol. 15, (no. 11), pp. 1285-91, 2007/Nov. | Journal Article
 
B5-01: Phase III trial of cisplatin (P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients (pts) with inoperable stage III non-small cell lung cancer (NSCLC): HOG LUN 01-24/USO-023
Hanna, Nasser⋅Hanna, Nasser⋅Hanna, Nasser⋅Neubauer, Marcus⋅Neubauer, Marcus⋅Neubauer, Marcus⋅McGarry, Ronald⋅McGarry, Ronald⋅McGarry, Ronald⋅Govindan, Ramaswamy⋅Govindan, Ramaswamy⋅Govindan, Ramaswamy⋅Johnson, Cynthia⋅Johnson, Cynthia⋅Johnson, Cynthia⋅Yiannoutsos, Constantin⋅Yiannoutsos, Constantin⋅Yiannoutsos, Constantin⋅Breen, Tim⋅Breen, Tim⋅Breen, Tim⋅White, Angela⋅White, Angela⋅White, Angela⋅Ansari, Rafat⋅Ansari, Rafat⋅Ansari, Rafat⋅Einhorn, Lawrence⋅Einhorn, Lawrence and Einhorn, Lawrence
Journal of Thoracic Oncology, vol. 2, (no. 8), pp. S346, August 2007. | Journal Article
 
E11-04: The role of irinotecan in the treatment of small cell lung cancer
Hanna, Nasser
Journal of Thoracic Oncology, vol. 2, (no. 8), pp. S254, August 2007. | Journal Article
 
Extended Lung Cancer Incidence Follow-up in the Mayo Lung Project and Overdiagnosis
Hanna, Nasser H
Yearbook of Oncology, vol. 2007, pp. 172, 2007-01-00. | Journal Article
 
Introduction
Hanna, Nasser H
Yearbook of Oncology, vol. 2007, pp. 161, 2007-01-00. | Journal Article
 
P3-091: A Phase I study of continuous oral treatment with the triple angiokinase inhibitor BIBF 1120 together with pemetrexed in previously treated patients with non-small cell lung cancer
Hanna, Nasser⋅Ellis, Peter⋅Stopfer, Peter⋅Shapiro, David and Gyorffy, Steve
Journal of Thoracic Oncology, vol. 2, (no. 8), pp. S718, 2007-08-01. | Journal Article
 
PD4-3-4: Correlation of pemetrexed (PEM) NSCLC exposure-response relationships (ERRs) to clinical study results from western and Japanese patient populations
Latz, Jane⋅Adachi, Susumu⋅Symanowski, James⋅Nakagawa, Kazuo⋅Tamura, Tokuhiro⋅Hanna, Nasser⋅Cullen, Michael⋅Falcoz, Christine⋅Musib, Luna and Calvert, Hilary
Journal of Thoracic Oncology, vol. 2, (no. 8), pp. S456, August 2007. | Journal Article
 
Prognostic factors in stage III non-small-cell lung cancer.
Ademuyiwa, Foluso O⋅Johnson, Cynthia S⋅White, Angela S⋅Breen, Timothy E⋅Harvey, Jayme⋅Neubauer, Marcus and Hanna, Nasser H
Clinical lung cancer, vol. 8, (no. 8), pp. 478-82, 2007/Sep. | Journal Article
 
Prognostic Factors in Stage III Non–Small-Cell Lung Cancer
Ademuyiwa, Foluso⋅Johnson, Cynthia⋅White, Angela⋅Breen, Timothy⋅Harvey, Jayme⋅Neubauer, Marcus and Hanna, Nasser
Clinical Lung Cancer, vol. 8, (no. 8), pp. 482, 2007. | Journal Article
 
The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer.
Weiss, Glen J⋅Rosell, R⋅Fossella, Frank V⋅Perry, Michael C⋅Stahel, R⋅Barata, F⋅Nguyen, B⋅Paul, S⋅McAndrews, P⋅Hanna, Nasser H⋅Kelly, K and Bunn, Paul A
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, vol. 18, (no. 3), pp. 453-60, 2007/Mar. | Journal Article
2006
A phase II study of methylphenidate for the treatment of fatigue.
Hanna, Amy⋅Sledge, George W⋅Mayer, Mary L⋅Hanna, Nasser⋅Einhorn, Lawrence⋅Monahan, Patrick O⋅Daggy, Joanne and Bhatia, Sumeet
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, vol. 14, (no. 3), pp. 210-5, 2006/Mar. | Journal Article
 
Chemotherapy and Radiotherapy in the Treatment of Resectable Non-Small-Cell Lung Cancer
Bernstein, Eric⋅Herbert, Scott and Hanna, Nasser
Annals of Surgical Oncology, vol. 13, (no. 3), pp. 291-301, Mar 2006. | Journal Article
 
Elderly Patients Benefit From Second-Line Cytotoxic Chemotherapy: A Subset Analysis of a Randomized Phase III Trial of Pemetrexed Compared With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
Weiss, Glen⋅Weiss, Glen⋅Weiss, Glen⋅Langer, Corey⋅Langer, Corey⋅Langer, Corey⋅Rosell, Rafael⋅Rosell, Rafael⋅Rosell, Rafael⋅Hanna, Nasser⋅Hanna, Nasser⋅Hanna, Nasser⋅Shepherd, Frances⋅Shepherd, Frances⋅Shepherd, Frances⋅Einhorn, Lawrence⋅Einhorn, Lawrence⋅Einhorn, Lawrence⋅Nguyen, Binh⋅Nguyen, Binh⋅Nguyen, Binh⋅Paul, Sofia⋅Paul, Sofia⋅Paul, Sofia⋅McAndrews, Patrick⋅McAndrews, Patrick⋅McAndrews, Patrick⋅Bunn, Paul⋅Bunn, Paul⋅Bunn, Paul⋅Kelly, Karen⋅Kelly, Karen and Kelly, Karen
Journal of Clinical Oncology, vol. 24, (no. 27), pp. 4411, 20060920. | Journal Article
 
In Reply
Hanna, Nasser H
Journal of Clinical Oncology, vol. 24, (no. 32), pp. 5176, 2006-11-10. | Journal Article
 
Phase II study of BBR 3464 as treatment in patients with sensitive or refractory small cell lung cancer.
Hensing, Thomas⋅Hanna, Nasser H⋅Gillenwater, Heidi H⋅Gabriella Camboni, M⋅Allievi, Cecilia and Socinski, Mark A
Anti-cancer drugs, vol. 17, (no. 6), pp. 697-704, 2006/Jul. | Journal Article
 
Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer.
Hanna, Nasser H⋅Lilenbaum, Rogerio⋅Ansari, Rafat⋅Lynch, Thomas⋅Govindan, Ramaswamy⋅Janne, Pasi A and Bonomi, Philip
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 24, (no. 33), pp. 5253-8, 2006/Nov/20. | Journal Article
 
Phase II Trial of Cetuximab in Patients With Previously Treated Non–Small-Cell Lung Cancer
Hanna, Nasser⋅Lilenbaum, Rogerio⋅Ansari, Rafat⋅Lynch, Thomas⋅Govindan, Ramaswamy⋅Jänne, Pasi and Bonomi, Philip
Journal of Clinical Oncology, vol. 24, (no. 33), pp. 5258, 20061120. | Journal Article
 
Postoperative Chemotherapy for N2 Non–Small-Cell Lung Cancer: Conclusions Are Not Black and White, but Gray
Hanna, Nasser H⋅Hanna, Nasser H⋅Einhorn, Lawrence H and Einhorn, Lawrence H
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 24, (no. 35), pp. 5612, 2006-Dec-10. | Journal Article